Registration Number
0224U032974,
(0124U003982)
, R & D reports
Title
Development of personalized criteria for assessing high cardiovascular risk based on markers of cellular senescence
popup.stage_title
Оцінка високого кардіо-васкулярного ризику за маркерами клітинного старіння у хворих, які перенесли невідкладні кардіологічні стани до пандемії COVID-19
Head
Parkhomenko Oleksandr M., Доктор медичних наук
Registration Date
13-12-2024
Organization
STATE INSTITUTION NATIONAL SCIENTIFIC CENTER THE M.D. STRAZHESKO INSTITUTE OF CARDIOLOGY, CLINICAL AND REGENERATIVE MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE
popup.description1
To establish novel, complex justified pathogenetic approaches for assessing the risk of cardiovascular complications in patients who underwent emergency cardiac conditions, based on markers of cellular senescence, to enhance the effectiveness of personalized therapy
popup.description2
Enhancing the effectiveness of cardiac patients treatment who underwent emergency conditions depends on an understanding of disease progression mechanisms, the identification of high-risk groups, and the ability to correct these processes. The project aims to establish a fundamental association between cellular senescence and the pathogenetic features of cardiovascular pathology in high-risk patients. By conducting correlation analyses of cellular senescence markers, endothelial dysfunction, and other traditional clinical risk markers, the project will define new diagnostic and prognostic criteria for a comprehensive clinical assessment of cardiovascular homeostasis. Early individualized risk diagnosis and pathogenetic treatment, based on the developed criteria, will enable the implementation of a novel patient management strategy, reducing the disability and mortality. This holds significant economic and social importance in the context of maintaining national security.
The aim of work: : To establish novel, complex justified pathogenetic approaches for assessing the risk of cardiovascular complications in patients who underwent emergency cardiac conditions, based on markers of cellular senescence, to enhance the effectiveness of personalized therapy
Product Description
popup.authors
Kyryk Vitalii M.
Skarzhevskyi Oleksandr A.
Ustymenko Alina M.
Khomiakov Dmytro V.
Tsupykov Oleh M.
popup.nrat_date
2024-12-13